Protein kinase C isoenzymes in human neuroblasts involvement of PKCε in cell differentiation  by Ponzoni, M. et al.
Volume 322, number 2, 120-124 FEBS 12413 
0 1993 Federation of European Biochemical Societies 00145793/93/$6.00 
May 1993 
Protein kinase C isoenzymes in human neuroblasts 
Involvement of PKC& in cell differentiation 
M. Ponzoni, E. Lucarelli, M.V. Corrias and P. Cornaglia-Ferraris 
Pediatric Oncology Laboratory, G. Gaslini Children’s Hospital, Genoa, Italy 
Received 1 March 1993; revised version received 24 March 1993 
Although neuronal cells are a major target of phorbol ester action, the activity of the various protein kinase C (PKC) isoenzymes have not been 
studied in detail in human neuroblasts. Differentiation of the LAN-5 human neuroblastoma cell line by interferon-y (IFN-y) is accompanied by 
a twofold increase in PKC activity. Since PKC is a multigene family, we investigated which isoforms were expressed in control and differentiated 
cells, and which of these isoenzymes is involved in neuronal differentiation. We found that: (1) PKC activity is higher in differentiated than in 
undifferentiated cells; (2) RT-PCR analysis howed the expression of mRNA for PKCa, -y, -6, -E and -c and the absence of mRNA forp in untreated 
LAN-5 cells; (3) Western blot evaluation with PKC isoform-specific antibodies howed the same pattern of PKC expression in non-differentiated 
cells; (4) Expression of PKCE mRNA was significantly enhanced by IFN-y-induced differentiation, while the other isoforms were not affected; 
(5) Differentiation of LAN-5 cells with IFN-I or retinoic acid induced overexpression of the PKCE protein, while inhibition of cell proliferation 
by fetal calf serum starvation was without effect. These findings suggest hat expression of PKCE isoform is tightly coupled with neuronal 
differentiation and may play a role in the maintenance of the differentiated state. 
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1. INTRODUCTION 
Protein kinase C (PKC) is a phospholipid-dependent 
protein kinase which phosphorylates proteins on serine 
and threonine residues and binds phorbol ester [l-3]. 
PKC is now known to be a multigene family with at 
least seven members: a, B, y, 8, E, c and n/L [14]. In 
addition, the j? gene undergoes differential splicing, re- 
sulting in two distinct RNA products, /3, and /I2 [5]. The 
PKC family can be divided into two groups. PKCa, B 
and y have four constant domains, C14, at which a 
high degree of sequence homology exists between the 
different isoenzymes [3]. It has been suggested that the 
aspartic acid- and the glutamic acid-rich sequences in 
the C2 domain are involved in Ca2’ interaction [6]. Al- 
though PKCG, E, c and n/L have Cl, C3, and C4, they 
lack the C2 domain and consistently show a Ca” inde- 
pendent activation [7-91 
PKC isoenzymes are important regulatory enzymes. 
They are involved in a large number of cellular proc- 
esses, including cellular proliferation, gene regulation, 
ion channel and receptor activation, and neurotransmit- 
ter release [3,10]. PKCs are highly expressed in brain 
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tissue [l l] and they play a role in several brain-specific 
functions, including long-term potentiation, neurite 
outgrowth, and neuronal differentiation [12,131. Several 
neuroblastoma (NB) cell lines can be induced to differ- 
entiate to cells with neuronal characteristics and have 
been used as models for neuronal differentiation [14]. 
Human LAN-5 NB cells can be induced to mature after 
treatment with retinoic acid (RA) and interferon-y 
(IFN-y) giving rise to non-proliferative terminally dif- 
ferentiated ganglion-like cells [15,16]. Studies from a 
number of laboratories have demonstrated that changes 
in the activity of PKC may be involved in the differenti- 
ation pathway of several cell types indicating both in- 
creased expression and down-regulation of different 
PKC isoenzymes [17-201. A recent study demonstrates 
that PKC isoforms are capable of selective isotype 
switching and their expression may differ with respect 
to the inducer used to stimulate differentiation [21]. 
Moreover, several attempts to correlate PKC activity to 
NB differentiation did not afford any consistent result 
[22-251. The discovery of multiple PKC isoforms led to 
the suggestion that different isoenzymes erve distinct 
functions through differences in activator and/or sub- 
strate specificity [2]. 
The aim of the present study was therefore to investi- 
gate in more detail the PKC activity and the mRNA and 
protein levels of the various isoenzymes during neural 
cell differentiation using the human NB cell line LAN-5 
as a model. 
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2. MATERIALS and METHODS 
2.1. Chemicals 
Human recombinant IFN-J and human recombinant Tumour Ne- 
crosis Factor-d (TNF) were obtained from Genzyme Corporation 
(Boston, MA, USA) and kept in aliquots (1000 IU/,@ in phosphate- 
buffered saline (PBS) (Flow Laboratories, Milan, Italy) plus 0.1% 
bovine serum albumine (BSA) at -80°C. RA (Sigma, St. Louis, MO, 
USA) was prepared at 10-j M in DMSO every week and kept at 
-20°C. All other reagents of biochemistry or molecular biology grade 
were obtained from Sigma. 
2.2. Cell cultures and treatments 
LAN-5 NB cell line was a gift of R. Seeger [26]. Cells were main- 
tained in the logarithmic phase of growth in 75 cm’ plastic culture 
flasks (Falcon plastic, Oxnard, CA, USA) in RPM1 1640 medium 
(Seromed, Biochrom KG, Berlin, Germany), supplemented with 15% 
heat-inactivated fetal calf serum (FCS) (Seromed), sodium penicillin 
G (50 W/ml), and streptomycin sulfate (50,@ml) (complete medium) 
at 37°C in a 5% CO,-95% air humidified incubator. Cells were split 
following treatment with 1 mM EDTA in Hank’s salts solution 
(Seromed), washed, counted, and replated in fresh complete medium. 
Cells were treated with 1000 IU/ml IFN-y or 200 IU/ml TNF or 10e6 
M RA or starved in 2% FCS-complete medium for five days as previ- 
ously described [27,28]. U937(ATCC-CRL 1593) and PC-12 cells 
(ATCC-CRL1721) were cultured as above. 
2.3. Protein kinase C activity assay 
After the end of the culture period, the cells were lysed on ice with 
20 mM Tris, pH 7.5,2 mM EDTA, 0.5 mM EGTA, 1 mM dithiothre- 
itol, 1% Triton X-100,0.5 mM phenylmethylsulfonil fluoride (PMSF), 
and 10 &ml aprotinin. The homogenates were mixed for 1 h at 4°C 
and centrifuged at 100,000 x g for 1 h at 4°C. The supernatant was 
loaded onto a DEAE-cellulose column and PKC activity was semipu- 
rified as described [29]. Total cellular PKC content was determined 
using histone type III-S as substrate as described [30]. Specific PKC 
activity is expressed as pmol “P transferred per mg substrate protein 
per min. in the presence of phosphatidylserine, diolein, and CaCI, 
minus that in the presence of Cal’ only. 
2.4. RNA amplification and reverse transcriptase-polymerase chain re- 
action (RT-PCR) 
Total cellular RNA was prepared according to Chomczynski and 
Sacchi [31]. First strand synthesis and polymerase chain reaction were 
performed by means of a commercial kit (Perkin-Elmer, Norwalk, CT, 
USA). For each reaction 1 pg of total RNA was reverse transcribed 
by priming with random primers and then amplified with the isoform 
specific oligonucleotide primers synthesized with a Applied Biosystem 
391 DNA synthetizer and described in Table I. The same RNAs were 
primed with the commercial primers for the housekeeping ene 
G3PDH (Clontech, Palo Alto, CA, USA). Amplification conditions 
were: 1 min at 94°C 1 min at 58°C and 1 min at 72°C for 30 cycles. 
The amplified products were separated by electrophoresis on a 10% 
acrylamide gel run in TBE buffer (TBE is 90 mM Tris-HCI, pH 8.3, 
90 mM Boric acid, 2 mM EDTA) at 200 V for 2 h. Restriction enzyme 
digestions were performed according to standard procedures. The 
same RT-PCR technique was used to quantify the RNA for the norad- 
renaline transporter of LAN-5 cells [32]. 
2.5. Preparation of cell lysates and Western blot analysis 
After detachment from flasks, cells were washed twice with ice-cold 
PBS and resuspended at lO’/ml in lysing buffer (20 mM Tris-HCI, pH 
7.5, 150 mM NaCI, 1 mM PMSF, 10 pg/ml leupeptin, 10 &ml pep- 
statin, and 0.5% Triton X-100. Brains from lo-week-old Sprague- 
Dawley rats, from Charles River (Calco, Italy) were homogenized in 
the same lysing buffer as above. After 60 min on ice, cell membranes 
were pelleted by centrifugation at 100,000 x g for 60 min at 4°C. 100 
fig of cytosolic proteins, determined with the Coomassie protein rea- 
gent (Pierce, Rockfort, IL, USA) were loaded onto a 7.5% SDS- 
polyacrylamide gel, electrophoresed at 35 mA for 5 h and then elec- 
troblotted onto Hybond C super membranes (Amersham, Bucking- 
amshire, UK). After blocking in 3% dry milk in TBST (10 mM Tris- 
HCI, pH 8.0, 154 mM NaCl, 0.05% Tween 20), filters were incubated 
overnight with the various isoform-specific antibodies. Anti a and /I 
isoforms were monoclonal antibodies purchased from UBI (Lake 
Placid, NJ, USA), while anti y, S, E, and c isoform antibodies were 
raised in rabbit and obtained from Gibco-BRL (Gaithersburg, MD, 
USA). Specific PKC antigen peptides were obtained from Gibco- 
BRL. Filters were sequentially incubated for 2 h with a biotinylated 
anti mouse or anti rabbit Ig and for I h with a streptavidine-alkaline 
phosphatase conjugate, and then developed with NBT and BCIP as 
indicated by ICN (Costa Mesa, CA, USA). 
3. RESULTS AND DISCUSSION 
Previous reports have documented changes in PKC dur- 
ing neuronal maturation [22-24,331. While these studies 
have demonstrated modulation of some PKC isoen- 
zymes during treatment of neural cells with PKC inhib- 
itors or they have focused on only few PKC isoforms, 
they have, however, failed to address whether true dif- 
ferentiation-promoting agents, such as IFN-)I and RA, 
affect the individual isoforms in a differential manner 
within the same neuronal model. In this study, changes 
in total PKC activity in LAN-5 human NB cells treated 
with IFN-)I over the time course of full differentiation 
have been documented. Moreover, induction of NB ter- 
minal differentiation with IFN-y or RA is followed by 
a significant selective enhancement of the mRNA and 
protein level for the PKCE isoform. 
We first measured PKC activity in detergent-solubil- 
ized cell homogenates under conditions where enzyme 
activity varies linearly with enzyme concentration [30]. 
The total specific activity of PKC in LAN-5 cells rose 
in a time-dependent manner with the IFN-y treatment, 
reaching a maximum (approximately twofold the level 
of untreated cells) after five days of culture (Fig. l), 
concomitant with acquisition of the neuronal marl 
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Fig. I. Time course of IFN-y treatment on total PKC activity of 
LAN-5 cells. Cells were treated with 1000 W/ml of IFN-y. Values are 
expressed as means f S.D. of four independent experiments ach done 
in triplicate. 
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ogy [16]. The magnitude of the unspecific PKC activity 
measured in the presence of only CaCl, was about 10% 
in all the time courses examined. The multiple effects 
attributed to PKC [3,10,12,13] indicate that PKC serves 
as a central mediator involved in the transduction of 
various signals in a wide variety of cell types, but how 
this enzyme can fulfill so many divergent functions is 
not understood. PKC is a growing multigene family and 
many studies indicate that PKC isoenzymes are ex- 
pressed in a tissue-specific manner and that individual 
PKC isoforms might play cell type-specific roles in cel- 
lular responses and differentiation [3,10-13,17-211. 
Since IFN-y is able to induce neurogenesis and bio- 
chemical maturation of LAN-5 cells [16], as well as 
documented changes in PKC activity (Fig. l), experi- 
ments were undertaken to address whether changes in 
the individual isoforms of PKC could account for the 
observed differences in PKC activity. Initial characteri- 
zation of the model was obtained by investigating the 
RNA levels of the different kinase isoenzymes in cul- 
tured LAN-5 cells by RT-PCR analysis using specific 
oligonucleotide primers deduced from the sequences of 
the PKC cDNA clones (Table I). We found that LAN-5 
cells express five PKCs: a, y, S, E, and c, the CI and c 
being the prominent constitutive isoforms (Fig. 2). In 
contrast to a previous observation on another NB cell 
line [23] we did not find any PKC /I mRNA. This could 
be ascribed to differences in method evaluation or to a 
further cell clone-specificity. The specificity of the mes- 
sages was verified by the expected sizes, by positive and 
negative controls (Fig. 2, lanes 1 and 2, respectively), 
and by the expected restriction digestion patterns (data 
not shown). Induction of differentiation by treatment of 
LAN-5 cells with 1000 III/ml of IFN-)I for five days 
induced a significant increase in the level of PKCE 
RNA, while the other isoforms were totally unchanged 
(Fig. 2). 
To investigate the regulation of PKC isoenzymes by 
IFN-y induction, we performed Western blot analysis 
with PKC isoenzyme-specific antibodies. No PKC/? im- 
munoreactivity could be found in untreated and IFN-)I- 
treated cells, confirming that these NB cells do not ex- 
press this PKC isoform. Antibodies against PKCa, y, 
S, and C recognized single major immunoreactive bands 
of 85 (PKCa and y) and 80 kDa (PKCS and 0 in 
untreated LAN-5 cells (Fig. 3, lanes 3). These bands 
were not modulated by the IFN-y-treatment, confirm- 
ing the data of the RT-PCR. Moreover, the antibody to 
PKCE recognized a band of about 90 kDa in the control 
cells that was drastically enhanced by the induction with 
IFN-y (Fig. 3, lanes 4), indicating a possible involve- 
ment of the PKCE isoform in the IFN-y-induced neu- 
ronal differentiation. It could be noted that the pattern 
of isoenzyme expression seen in RNA is also reflected 
at the protein level, suggesting that PKC expression in 
NB cells is regulated mainly at the mRNA level. 
To further address the question whether PKCE isoen- 
zyme is generally involved in neuronal maturation and 
is not simply linked to a selective IFN-y-dependent 
modulation, we cultured LAN-5 cells for five days in the 
presence of RA or TNF or 2% FCS, and then we analy- 
sed the level of PKCE protein. RA is able to induce 
terminal differentiation of LAN-5 cells, while these cells 
are completely resistant to the TNF action [27], al- 
Table I 
Sequence of isoform specific oligonucleotide primers used for RT-PCR analysis 
Isoform Sequence 
5’+3’ 
Positionb Size’ Rep 
a 
/I I/II 
Y 
6 
& 
r 
F” GGGACGAGGAAGGAAACATGGAAC 898-921 177 38 
R” AAC TCC CCT TTC CCA ACA CCA TGA 1052-1075 
F CCAGAAGGAAGTGAGGCCAATGAAG 938-962 226 39 
R AGC TCA TCT GTG CCT TTT CGT TCT G 1139-1164 
F TACCCCCTGGAATTGTATGAG 11141134 128 39 
R GGAGATGTGCAGTCGTCCAG 1223-1242 
F AGT GAC CCA GAA AGC TTC CCG GA 1231-1254 238 7 
R TACCTTTCCTTGCCCTTCAGTTCTGC 14441469 
F AGC CGG CTT CTG GAA ACT CCC 11761196 264 7 
R AGCTGCCTTTGCCTAACACCTTGAT 14161440 
F TGT CAT GCC TTC CCA AGA GCC TC 258-280 231 7 
R ATAGCTTCCACGCCCGATGACTCT 466489 
“F = Forward, R = Reverse 
bPosition of the primers on the clone sequence 
“Expected size of the amplified fragment (bp) 
dReference for the clone sequence. 
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Fig. 2. RT-PCR analysis of PKC isoforms. The expression of the six 
PKC isoforms tested and of the housekeeping gene G3PDH, were 
analyzed in: control cell lines (U937, positive for LX,/?, and y isoforms; 
PC-12, positive for 6, a, and 6 isoforms), lane 1; negative control 
(absence of template RNA), lane 2; untreated LAN-5 cells, lane 3; 
IFN-y-treated (1000 IU/ml) LAN-5 cells for 5 days, lane 4. Molecular 
weight markers from 4~ 174 RF DNA digested with Hue111 are shown 
on the left side. 
though they bear high-affinity cell surface TNF-recep- 
tors [34]. Moreover, starvation of these cells in 2% FCS 
inhibits cell proliferation without affecting neural matu- 
ration [28]. Fig. 4 clearly shows that only IFN-y (lane 
3) and RA (lane 4) treatments were able to enhance 
PKCE levels, while the other treatments were without 
effect (lanes 5,6). Immunoreactivity against the PKCE 
protein was blocked by the presence of a specific antigen 
peptide (lane 7) confirming the specificity of the 
isoform induced. 
The discrepancy between the relatively modest (two- 
fold) increase in PKC activity observed after differenti- 
ation of LAN-5 cells with respect to the marked en- 
hancement of mRNA and protein levels of PKCE could 
have several reasons. Histone type III-S is a relatively 
80, 
85~ 
80, 
90, 
80- 
a 
Fig. 3. Western blot analysis of PKC isoforms, 100 pug of cytosolic 
proteins from: rat brain, lane I; U937 cells, lane 2; untreated LAN-5 
cells, lane 3; LAN-5 cells treated with 1000 IU/ml of IFN-)I for 5 days, 
lane 4, were electrophoresed and probed with the isoform specific 
antibodies as described in section 2. Molecular weights are indicated 
on the left. 
poor substrate for PKCE [35] i.e., although PKCE binds 
phorbol ester (PMA) and displays phospholipid- and 
PMA-dependent kinase activity on substrate peptides, 
it does not phosphorylate histone to a significant extent. 
Fig. 4. Modulation of PKCs expression during NB cell differentiation. 
100 pg of cytosolic proteins from: rat brain, lane 1; untreated LAN-5 
cells, lane 2; LAN-5 cells treated for 5 days with 1000 IUlml IFN-y, 
lane 3, or with lo-’ M RA, lane 4, or with 200 IU/ml TNF, lane 5, 
or cultured in the presence of 2% FCS, lane 6, were electrophoresed 
and probed with the PKCE specific antibody as described in section 
2. The blot in lane 7, containing the same amount of protein as lane 
3, was incubated for 2 h with the immunogen PKCE peptide and then 
probed with the PKCs antibody. 
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Therefore our measurements of PKC activity in cell 
homogenates may have underestimated the amount of 
PKCE present. Moreover, although DEAE chromatog- 
raphy removes endogenous inhibitors that interfere 
with the PKC assay [36], some inhibitory activity can 
still be present in the preparation. Finally, since meas- 
urements of PKC activity results from the combined 
effects of PKC, proteases, phosphatases, and inhibitors, 
the PKC activity assay with total cell homogenates may 
have underestimated IFN-y-induced increase in PKC 
levels. 
These results clearly demonstrate modulation of 
PKCE isoform protein and RNA levels via specific dif- 
ferentiation-inducing agents and support the notion 
that each of these isotypes plays a discriminate role in 
the cell. Several proteins which participate in neurofil- 
ament reorganization during neural differentiation are 
themselves substrates for PKC [37]. Moreover, PKCE is 
nearly exclusively localized in the membranes and proc- 
esses in NB cells [23]. Thus, it is possible that both the 
PKCE isoform and particular substrates colocalize dur- 
ing neurite extension and that proximal distribution of 
the kinase and substrate plays a key role in the acquisi- 
tion of neuronal phenotype. 
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